Home > Insider Trading > Filing (0001639691-22-000031)

Filing Details

Accession Number:: 0001639691-22-000031
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-31 17:16:50
Reporting Period:: 2022-03-29

Accepted Time:: 2022-03-31 17:16:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1639691	Livanova Plc	LIVN	Electromedical & Electrotherapeutic Apparatus (3845)	981268150

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1686894	Damien Mcdonald	20 Eastbourne Terrace London X0 W2 6LG	Ceo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Disposition	2022-03-29	2,784	$81.50	76,993	No	4	S	Direct
Ordinary Shares	Acquisiton	2022-03-30	3,213	$0.00	80,206	No	4	M	Direct
Ordinary Shares	Disposition	2022-03-30	1,511	$81.50	78,695	No	4	F	Direct
Ordinary Shares	Acquisiton	2022-03-30	8,607	$0.00	87,302	No	4	M	Direct
Ordinary Shares	Disposition	2022-03-30	4,046	$81.50	83,256	No	4	F	Direct
Ordinary Shares	Acquisiton	2022-03-30	5,120	$0.00	88,376	No	4	M	Direct
Ordinary Shares	Disposition	2022-03-30	2,407	$81.50	85,969	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Restricted Stock Units	Disposition	2022-03-30	3,213	$0.00	3,213	$0.00
Ordinary Shares	Restricted Stock Units	Disposition	2022-03-30	8,607	$0.00	8,607	$0.00
Ordinary Shares	Restricted Stock Units	Disposition	2022-03-30	5,120	$0.00	5,120	$0.00
Ordinary Shares	Restricted Stock Units	Acquisiton	2022-03-30	18,283	$0.00	18,283	$0.00
Ordinary Shares	Performance Stock Units	Acquisiton	2022-03-30	9,141	$0.00	9,141	$0.00
Ordinary Shares	Performance Stock Units	Acquisiton	2022-03-30	18,283	$0.00	18,283	$0.00
Ordinary Shares	Performance Stock Units	Acquisiton	2022-03-30	9,141	$0.00	9,141	$0.00
Ordinary Shares	Stock Appreciation Rights	Acquisiton	2022-03-30	35,483	$0.00	35,483	$82.04

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,213	No	4	M	Direct
17,213	No	4	M	Direct
15,357	No	4	M	Direct
18,283	No	4	A	Direct
9,141	No	4	A	Direct
18,283	No	4	A	Direct
9,141	No	4	A	Direct
35,483	No	4	A	Direct

Footnotes

Shares sold pursuant to a Rule 10b5-1 Plan adopted by reporting person on November 9, 2021.
Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.
The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability.
Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement.
On March 30, 2019, reporting person was granted RSUs subject to a four-year vesting schedule, the first vesting for which occurred on March 30, 2020. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.
This number reflects the number of derivative securities beneficially owned following reported transaction for this specific grant.
On March 30, 2020, reporting person was granted RSUs subject to a four-year vesting schedule, the first vesting for which occurred on March 30, 2021. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.
On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting schedule, the first vesting for which occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.
On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting schedule, the first vesting occurring on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.
Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Plan and the award agreement.
On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on how the Company's cumulative adjusted free cash flow (FCF) for performance period 2022-2024 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting.
On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2022 and ending December 31, 2024 relative to the total shareholder return of a peer group of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.
On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2022-2024 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.
On March 30, 2022, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting schedule, the first vesting occurring on March 30, 2023. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement.